Breaking News
Get 45% Off 0
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
3 Great Mutual Fund Picks For Your Retirement - March 24, 2020 By Zacks Investment Research - Mar 23, 2020

If you're invested in any of the funds in our "Magnificent Retirement Mutual Funds" list, congratulations on owning some of the best managed and top-performing mutual funds. If you are lucky enough to...

Zillow Group (ZG) Halts Home Buying Amid Coronavirus Crisis By Zacks Investment Research - Mar 23, 2020

Zillow Group, Inc. (NASDAQ:ZG) recently announced that it will temporarily stop home buying for Zillow Offers in all of its markets due to the global coronavirus pandemic. The company has stated...

B2Gold To Temporarily Suspend Masbate Mine In The Philippines By Zacks Investment Research - Mar 23, 2020

B2Gold Corp. (NYSE:BTG) announced that while it is continuing to operate Fekola mine in Mali and Otjikoto in Namibia, it has temporarily suspended mining at its Masbate mine in the Philippines owing...

Top Ranked Income Stocks To Buy For March 24th By Zacks Investment Research - Mar 23, 2020

Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 24th:AbbVie Inc (NYSE:ABBV). (ABBV): This biopharmaceutical company has witnessed the Zacks...

Markets Up On Recovery Hopes By Zacks Investment Research - Mar 23, 2020

Tuesday, March 24, 2020Pre-market futures are up big at this hour, roughly 50 minutes before today’s opening bell (if there’s anyone there to ring it…). The Dow is in the green 830...

Eiger Completes NDA Submission Of Progeria Drug Lonafarnib By Zacks Investment Research - Mar 23, 2020

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) announced that it has completed rolling submission of a new drug application (“NDA”) to the FDA for its pipeline candidate, lonafarnib. The...

AbbVie's Venclexta Combo Meets Endpoints In Leukemia Study By Zacks Investment Research - Mar 23, 2020

AbbVie (NYSE:ABBV) announced positive interim analysis data from a phase III study —VIALE-A —evaluating a combination regimen of its blood cancer drug, Venclexta (venetoclax) in...

Royal Dutch Shell (RDS.A) Surges: Stock Moves 7% Higher By Zacks Investment Research - Mar 23, 2020

Royal Dutch Shell (LON:RDSa) plc RDS.A was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than...

Why You Should Keep FMC Corp (FMC) Stock In Your Portfolio By Zacks Investment Research - Mar 23, 2020

FMC Corporation (NYSE:FMC) is poised to gain from strong demand for its herbicides and insecticides and its efforts to expand product portfolio and boost market position amid certain headwinds...

AT&T Gets Additional Spectrum Due To Coronavirus Crisis By Zacks Investment Research - Mar 23, 2020

AT&T Inc. (NYSE:T) has secured the Federal Communications Commission’s (“FCC”) Special Temporary Authority to use the additional spectrum to help meet Americans’ wireless...

Lower Risk In Your Portfolio With These ETFs By Zacks Investment Research - Mar 23, 2020

The coronavirus pandemic is showing no signs of slowdown leading to relentless selling in U.S. stocks. The S&P 500 erased $9 trillion from its value since the benchmark hit a record high last...

Hopes Of A Recovery Boosts Pre-markets By Zacks Investment Research - Mar 23, 2020

Pre-market futures are up big at this hour, roughly 50 minutes before today’s opening bell (if there’s anyone there to ring it…). The Dow is in the green 830 points, the Nasdaq +290...

Continue with Apple
Continue with Google
or
Sign up with Email